Aclaris Therapeutics所有资讯

Aclaris Therapeutics | 4：持股变动声明-高管 Walker Neal

05/03 16:26 (美东)

Aclaris Therapeutics | ARS：年度报告

04/25 07:05 (美东)

Aclaris Therapeutics | DEFA14A：其他

04/25 07:05 (美东)

Aclaris Therapeutics | DEF 14A：股东委托书决议

04/25 07:05 (美东)

Aclaris Therapeutics | 4：持股变动声明-高管 Walker Neal

04/03 17:05 (美东)

Aclaris Therapeutics | 8-K：重大事件

03/19 16:33 (美东)

Aclaris Therapeutics | 4：持股变动声明-高管 Balthaser Kevin

03/05 17:13 (美东)

Aclaris Therapeutics | 4：持股变动声明-高管 Monahan Joseph

03/05 17:12 (美东)

Aclaris Therapeutics | 4：持股变动声明-高管 Walker Neal

03/05 17:09 (美东)

Aclaris Therapeutics | 4：持股变动声明-董事 Powell Andrew Kenneth William

03/05 17:05 (美东)

Aclaris Therapeutics | 10-K：年度报表

02/27 07:35 (美东)

Aclaris Therapeutics | 8-K：Aclaris Therapeutics公布2023年第四季度和全年财务业绩，并提供公司最新情况

02/27 07:20 (美东)

Aclaris Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners II, L.P.(0.0%),VHCP Co-Investment Holdings II, LLC(0.0%)等

02/14 20:33 (美东)

Aclaris Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%)等

02/14 17:30 (美东)

Aclaris Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Kenneth Griffin(7.6%),Citadel Advisors LLC(6.1%)等

02/14 17:05 (美东)

Aclaris Therapeutics | SC 13G：超过5%持股股东披露文件-Millennium Management LLC(5.3%),Millennium Group Management LLC(5.3%)等

02/14 16:22 (美东)

Aclaris Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-TANG CAPITAL PARTNERS, LP(2.5%),Tang Capital Management, LLC(2.5%)等

02/14 16:03 (美东)

Aclaris Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Rock Springs Capital Management LP(4.23%),Rock Springs Capital LLC(4.23%)等

02/14 15:51 (美东)

Aclaris Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%)等

02/14 10:32 (美东)

Aclaris Therapeutics | SC 13G：超过5%持股股东披露文件-The Vanguard Group(6.67%)

02/13 18:18 (美东)